STRATEGIC SUPPLY AGREEMENTStrategic Supply Agreement • August 9th, 2018 • Kindred Biosciences, Inc. • Pharmaceutical preparations • New York
This Strategic Supply Agreement (this “Agreement”), dated as of June 26, 2018 (the “Effective Date”), is by and between Pall Corporation, a New York corporation having its principal place of business at 25 Harbor Park Drive, Port Washington, New York 11050 (“Pall”) and Kindred Biosciences, Inc., a Delaware corporation having its principal place of business at 1555 Bayshore Hwy. #200, Burlingame CA 94010 (“KindredBio”). Pall and Kindred Bio are collectively referred to herein as the “Parties” and individually as a “Party”.
AMENDMENT OF EQUITY AWARD AGREEMENTS KINDRED BIOSCIENCES, INC.Equity Award Agreements • August 9th, 2018 • Kindred Biosciences, Inc. • Pharmaceutical preparations
This Amendment of Equity Award Agreements (this “Amendment”) is made and entered into as of the date set forth on the signature page of this Amendment by and between Kindred Biosciences, Inc., a Delaware corporation (“KindredBio”), and the executive officer of KindredBio (the “Executive”) whose name is set forth on the signature page of this Amendment.
OPTION AGREEMENT AMENDMENT KINDRED BIOSCIENCES, INC.Option Agreement • August 9th, 2018 • Kindred Biosciences, Inc. • Pharmaceutical preparations
This Option Agreement Amendment (this “Amendment”) is made and entered into as of the date set forth on the signature page of this Amendment by and between Kindred Biosciences, Inc., a Delaware corporation (“KindredBio”), and the option holder (the “Option Holder”) whose name is set forth on the signature page of this Amendment.
